MedPath

Effect of Dapsone gel 5% in the treatment of mild to moderate acne

Phase 3
Recruiting
Conditions
Acne.
Acne vulgaris
L70.0
Registration Number
IRCT20220724055546N1
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
45
Inclusion Criteria

Patient with mild to moderate acne

Exclusion Criteria

Pregnant and lactating women
Known sensitivity to dapsone gel or benzoyl peroxide gel or preservatives in the drug
History of using systemic drugs in the previous 3 months
History of using topical antibiotics or retinoid compounds in the previous 1 month
History of using antibacterial soaps or topical exfoliants in the previous 2 weeks

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Acne severity based on the global acne grading system. Timepoint: At the beginning of the treatment, one, two and three months after the treatment. Method of measurement: Global Acne Grading System.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath